Introduction
Wakan-yaku is based on Chinese traditional medicines, and of historical development has been achieved as Japanese traditional medicines. In present, many of Wakan-yaku extracted prescriptions are systematized perfectly in Japan and are listing in the "National Health Insurance drug price list in Japan" as authorized medicines. There is a lot of Wakan-yaku prescription which seems to be effective in functionality psychiatric disease, such as depression. It may be effective to use Wakan-yaku for studies about generation mechanisms of psychiatric disease and development of new medicines, since validities and safety are already established as crude drugs of authorized medicines in Japan.
Hochuekki-to (HET) is a typical Wakan-yaku prescriptions for acting on the mood deficits with inappetent. The first description of HET appeared in Chinese famous ancient document for medicine "Neiwaishang Bianhuolun", which was written by Dong Yuan Li in 1247. The expression of "hochu" in Japanese means improving the digestive system function and "ekki" means profiting for mood vigor. HET is standardized in Japan as combination of 10 kinds of crude drug (see material and methods), and No.41 is given as the common number among major pharmaceutical companies in Japan.
I and co-workers has been reported that HET has antidepressantlike effects in learned helplessness test in mice [1] . We also found that HET is involved serotonin 2C receptor (5-HT2CR) function and the mRNA expression [2] as well as antidepressants [2] [3] [4] . 5-HT2CR has been reportedly suggested the concerning with the neuronal development [5] [6] [7] . It has been also reported that HET-or typical antidepressants-treatment strongly enhanced BNIP-3 mRNA expression in cloned neuronal cells by experiments starting from the results of DNA array [8] . Furthermore, mRNA expression of various neuronal factors as well as BNIP-3 dynamically changes during the cultivation time in rat primary cultured neuronal cells, suggesting that these reflect the making of the neuronal function and the network [9] .
In this report, the rat brain is used for experiments. The cloned and primary cultured cells were used as isolated system model of neuron in the brain in previous experiments, but it'll be important to consider an actual change in the brain. So, the distributions of BNIP-3 mRNA in the rat brain were studied by in situ hybridization method. As well as using the resting state MRI for small animal, influences of HET oral administration on the rat brain activities under medetomidinesedation condition were examined.
Materials and methods

Extraction of HET
The hot water extract of HET was made as previously reported [8] .
HET is a combination of 10 galenicals. All galenicals were purchased from Tochimoto Tenkai-do (Osaka, Japan). The daily dose of each galenical when HET uses in humans, the location where the plant source was grown, and the lot numbers are as follows: 4 A total of 98 g (4-fold of each) were combined and used for extraction with 900 ml of boiling water for 60 min. Galenicals were removed while the solution was still hot, and the extract was frozen to make freeze dried extract. The yield was 26%.
Animals
Male Wistar rats (Japan SLC Inc., Hamamatsu, Japan) were housed in the laboratory animal room maintained at 25°C with 65% humidity on a 12 h light/dark cycle. Animals were given food and water ad libitum. All experiments were conducted in accordance with Guiding Principles for Care and Use of Animals in the Field of Physiological Science of the Physiological Society of Japan.
Three-dimensional high-performance liquid chromatography (3D-HPLC) analysis of extracts
HET extract was filtered through membrane filter (0.22 μm) and then submitted for HPLC analysis (20 μl). The HPLC apparatus (Hitachi Ltd., Japan) consisted of a pump (L-2130) with analysis system software (Elite LaChrom); it was equipped with a photodiode array detector (UV 230-400 nm, L-2455), a system controller, an auto injector (L-2200), and a column oven (L-2300). The HPLC conditions were as follows: column, LaChrom Ultra C18 (5 μm, Lot No. 21D5-011; Hitachi Ltd., Japan) with 150 × 4.6 mm I.D.; elutant, (A) H 2 O containing 0.1% formic acid and (B) CH 3 CN containing 0.1% formic acid (a linear gradient was used from '95% A and 5% B' to '30% A and 70% B' for 90 min); temperature, 20 °C; and flow rate 0.2 ml/min.
In Situ Hybridization Digoxigenin-labeled antisense
To obtain the anti-BNIP-3 mRNA probe, the partial sequence of BNIP-3 cDNA for insert was isolated by RT-PCR methods from cDNA which made from rat brain total RNA by reverse transcription. The PCR mixture contained 1 µl of RT product, 1 µM of each primer, 1 mM dNTPs, 2.5 mM MgCl2, and 2 units of Taq polymerase in the reaction buffer. The primer sequences are GAA CTG CAC TTC AGC AAT GG (forward) and GCC AGC AGA TGA GAC AGT AA (backward). The Annealing temperature is 57 ℃. Obtained PCR product was treated by T4 DNA Polymerase to be smooth end followed by phosphorylation and ligated into the pBluescript vectors with smooth end which digested by SmaI. Anti-RNA probe was made using this insertcontaining pBluescript vector as a template. The vector has T3 and T7 primer reacting sites at both ends of the cloning site. From the fact that T7 RNA polymerase produced the antisense RNA probe in this experiment, the insert-containing vector was cut by HindIII to make the antisense probe.
The reactions to make the probe were performed using the digoxigenin (DIG)-conjugated UTP to label the probe. The incubation mixture contained HindIII-treated insert-containing vector as a template, 10 mM dithiothreitol, 0.2 mg/ml BSA, 1 mM each of ATP, CTP and GTP, 0.65 mM UTP with 0.35 µM DIG-conjugated UTP and T7 RNA polymerase in 20 ml of reaction buffer. After incubation for 60 min at 37°C, the reaction mixtures were further incubated with 0.1 mg/ml DNase I for 15 min, and then ethanol precipitated in the presence of 0.4 M LiCl and 25 mM EDTA. The resultant RNA probe labeled with DIG was further incubated in hydration buffer (80mM NaHCO 3 , 60mM Na 2 CO 3 , 6 mM dithiothreitol) at 60°C to generate fragments of about 200 -300 bp. The reaction was terminated by adding 0.3 M sodium acetate and 0.25 mg tRNA, and the product was precipitated with ethanol. The pellet was redissolved in sterile water. T3 RNA polymerase was similarly used to make the sense probe from the BamHI-digested insert-containing vector as a template.
To prepare histological sections, a non-treated rat was killed by decapitation, and the brain was removed, immediately frozen using powdered dry ice and stored at -80°C. Frozen brain was cut into sections (16 µm) at -18℃, mounted onto gelatin-coated slides, and air-dried. Before hybridization, sections were fixed with 4% (w/v) paraformaldehyde in phosphate-buffered saline (PBS) for 15 min, treated with by 0.5 µg/ml proteinase K, and acetylated. After prehybridization, the sections were hybridized overnight with DIGlabelled probe in hybridization buffer consisting of 5 X standard saline citrate (SSC: 150mM NaCl, 17mM sodium citrate, pH 7.0), 50% formamide, 2.7 X Denhardt's solution, 10 mM EDTA, 20 mM dithiothreitol, 0.25 mg/ml tRNA, and 10% dextran sulfate, at 55°C. The hybridized sections were washed with 2 X SSC at 55°C, treated with 50 µg/ml RNaseA for 30 min, washed with 50% formamide/2 X SSC at room temperature, dehydrated in ethanol and dried. The digoxigenin-labeled probe hybridized with mRNA was detected immunohistochemically using an alkaline phosphatase-conjugated antidigoxigenin antibody with 450 µg/ml nitroblue tetrazolium and 175 mg/ml X-phosphate as coloring-reaction substrates.
MRI scanning in the rat brain
The rat MRI scanning experiment under medetomidine sedation (0.3 mg/kg s.c.) was performed on a "4.7-T Unity Inova (Varian Inc.)" at the Yokohama Institute (Now on closedown) of BioView Inc under the company's conduction. HET (1.0 g/kg as estimated from the galenicals) was oral administered just before medetomidine treatment.
Results
The 3D-HPLC pattern of HET is shown in figure 1 . The analysis detected the following substances derived from the crude drug extract: chlorogenic acid from Angelicae Radix; hesperidin and narirutin from Citri Leiocarpae Exocarpium; [6] -gingerol from Zingiberis Rhizoma; liquiritin, isoliquiritin, apioliquiritin, apioisoliquiritin, and glycyrrhizic acid from Glycyrrhiza Radix; and 3-(3-hydroxy-4-methoxyphenyl)-2-(E)-propenoic acid and ferulic acid from Cimicifugae Rhizoma. As expected under these conditions, substances originating from Ginseng Radix, Astragali Radix, Zizyphi Fructus, Atractylodes Rhizoma, Bupleuri Radix could not be detected by this 3D-HPLC. Other peak in the chart also could not be determined the content name.
The resting state MRI result of oral administration of HET in medetonidine-sedative rat brain is indicated in figure 2 . The MRI signals were detected 15 and 60 min after administration of HET. The horizontal and coronal images are shown. Activation of the brain activity probably reflecting the rising of blood flow was observed around the deep side of backward of the brain at 15 min later of HET administration in horizontal section. In coronal section, almost same results were observed but activation signal in whole brain area was also seen by a place. These activation signals decreased at 60 min, but the activation signals were still remained weakly.
It has been found that HET and antidepressant increases BNIP-3 mRNA in cultivated nerve cells [8] . So, in this experiment, which region of the brain abundantly expressed BNIP-3 mRNA was detected in naive rat brain using the in-situ hybridization method. As a result, mRNA expression interestingly showed at high level in the depth site of the brain where the activation by HET was observed by MRI method.
Higher expression of BNIP-3 mRNA also observed in hippocampus especially in CA3 aria.
Discussion
The specially mentioned point of this article may be that MRI was used to study the effects of Wakan-yaku prescription in the brain, HET stimulated the activity in the basal brain area at 15 min after administration. Interestingly, the activated area is almost same as one of expression region of BNIP-3 ( Figure 3 ) which is a factor enhancing the expression by some antidepressant and HET. The enhancement of MRI signals by HET was rapid and transient, and almost recovered to the base level at 60 min.
although the results were still in preliminary step. Since the rat brain was small, it was difficult to analyse the MRI signal using the software like SPM12. Advancing improvement of analysing way will give us remarkable knowledge about the Wakan-yaku effect in the future. This paper has a value as the herald. The constant expression of BNIP-3 mRNA was also observed in the brain area of HET-activated. The author(s) previously reported that some antidepressants and HET enhance the BNIP-3 mRNA expression in cultured cells [8] , although it did not study HET's effect in the rat brain. Further consideration is fascinating about the physiological roles of BNIP-3 in the brain region activated by HET and other antidepressants. BNIP-3 is thought to have the function of mitochondrial cell death [10] . I have been reported, however, about the possibilities of other cellular functions, neurite extension and synaptogenesis [9] . Isolated primary cultured neuronal cell may reconstruct the neuronal function during the cultivation period with morphological changing and various mRNA expressions [5, 9] . BNIP-3 may have a role for this reconstruction by expecting from the results of mRNA expression pattern. Since BNIP-3 mRNA has variant [9] , the roles respective mRNAs will be also interested. In this report, abundant BNIP-3 mRNA expression was seen in the hippocampus and the brain stem where the neuronal activities are high in particular. Further detail studies for "BNIP-3 roles to the neuronal functions" and "the functional significance of the mRNA expression increase by antidepressants and HET" will lead to novel theories and discoveries.
MRI observation showed that the HET conspicuously activated the brain stem. This area includes raphe nucleus which has the function to release serotonin to the rest of the brain and central part of the HPA (hypothalamus-pituitary-adrenal gland) axis system which has the function to regulate the release of corticosterone as a stress hormone. HET seems to have some effort in these systems. Although it can't be shown as a dater, in experimental process, remarkable breathing restraint was observed just after administration of HET (1-2 minutes later). As it seems to be a synergistic effect with sedative action by medetomidine, the effect could be seen very rapidly. Because of the rapid response and HET's effort for digestive system, an ascending nerve system from stomach, not from adrenal, to hypothalamus may be involved in this HET-induce activation of the brain stem. Recently, studies using MRI method on depression and the mechanisms are increasing. There are many kinds of imaging reports about depression for examples; 1) the morphological study about the volumetric changes in the human brain area with major depressive disorder [11] , 2) antidepressant effect on pain stimulus in depression patients compared with healthy control using the ultra-high field functional MRI methods [12] , and 3) meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies [13] . Further detail examinations by MRI method about HET and other kinds of Wakan-yaku which have antidepressive effect are also interesting.
HET consists of ten kinds of crude drug. A Wakan-yaku prescription with crude drug constructions of resemblance to HET is Rikkunshito (RKT). RKT consists of eight kinds of crude drug, and six kinds are same as HET. RKT also acts on appetite increase as well as HET. Ghrelin, a peptide hormone released from stomach [14] , is reportedly involved in the RKT's appetite effect [15] . Participation to serotonin in the brain has been also indicated as RKT's effect [15] . Although there are no reports about ghrelin secretion by HET till now as far as I know, comparative experiments about the action mechanisms of RKT and HET is future's interest because of similar effects to digestive system. Not only about appetite increase, but also various actions are reported as ghrelin effects for growth hormone stimulus [16] , stomach movement control through vagus nerve [17] , glucose metabolism [18] and others.
This article shows the effects of a Wakan-yaku prescription, HET, in the brain using MRI and the BNIP-3 mRNA expression region in the brain by using in situ hybridization to compare the MRI results. The result was still preliminary, but the fascinating knowledge in the future was obtained. There are many kinds of prescriptions acting on the psychiatric functional disorders, especially for depression, are included in Wakan-yaku. The detail analysis of Wakan-yaku by functional-or resting state-MRI methods will give us novel thinking and remarkable viewpoints about treatment of the psychiatric functional disorders. 
